BioMarin Pharmaceutical
BMRN
#1749
Rank
A$17.42 B
Marketcap
A$90.71
Share price
2.23%
Change (1 day)
-14.41%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): A$1.06 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$3.09 Billion. In 2024 the company made an earning of A$0.81 Billion, an increase over its 2023 earnings that were of A$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.06 B31.59%
2024 A$0.81 B187.31%
2023 A$0.28 B26.07%
2022 A$0.22 B-298.51%
2021 -A$0.12 Billion78.04%
2020 -A$63.36 Million-55.36%
2019 -A$0.15 Billion-33.56%
2018 -A$0.22 Billion297.78%
2017 -A$53.71 Million-95.68%
2016 -A$1.25 Billion437.12%
2015 -A$0.24 Billion23.91%
2014 -A$0.19 Billion-29.25%
2013 -A$0.27 Billion49.23%
2012 -A$0.18 Billion171.11%
2011 -A$65.31 Million103.01%
2010 -A$32.17 Million-3903.54%
2009 A$0.84 M-98.31%
2008 A$50.03 M-189.7%
2007 -A$55.78 Million51.02%
2006 -A$36.94 Million-61.58%
2005 -A$96.13 Million-56.59%
2004 -A$0.23 Billion95.13%
2003 -A$0.12 Billion12.09%
2002 -A$0.11 Billion73.19%
2001 -A$58.45 Million18.32%
2000 -A$49.4 Million19.65%
1999 -A$41.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-A$0.78 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.17 Billion-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$41.08 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.62 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
A$7.45 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$0.42 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA